| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABOTEGRAVIR SODIUM | 4 | 0.0025 |
| 1 | EPINASTINE HYDROCHLORIDE | 1 | 0.0009 |
| 2 | RILPIVIRINE | 4 | 0.0006 |
| 3 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 2 | 0.0006 |
| 4 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 3 | 0.0005 |
| 5 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 6 | FLUOROMETHOLONE | 1 | 0.0003 |
| 7 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 2 | 0.0002 |
| 8 | ABACAVIR SULFATE | 2 | 0.0002 |
| 9 | CABOTEGRAVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 9 | 0.0001 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |
| 6 | Corticosteroid [EPC] | 1 | 0.0000 |